BackAlpha Tau Medical Ltd - Warrants (07/03/2027) Overview
Alpha Tau Medical Ltd - Warrants (07/03/2027)

Alpha Tau Medical Ltd - Warrants (07/03/2027) Return on Equity

Valuation check: DRTSW's ROE is -82.01%, below the sector sector average of -4.47%.

Get informed when a big investor buys or sells

+ Follow

ROE

-82.01%

Return on Equity

-82.01%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Alpha Tau Medical Ltd - Warrants (07/03/2027) (DRTSW) FAQ

Alpha Tau Medical Ltd - Warrants (07/03/2027) (DRTSW) currently reports a ROE of -82.01%. That is below the sector sector average of -4.47%. Use the charts on this page to explore Alpha Tau Medical Ltd - Warrants (07/03/2027)'s ROE history and peer comparisons.

Alpha Tau Medical Ltd - Warrants (07/03/2027)'s ROE of -82.01% is lower than the its sector sector average of -4.47%. That is roughly 1735.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Alpha Tau Medical Ltd - Warrants (07/03/2027)'s current -82.01% should be judged against industry norms (sector average: -4.47%) and against DRTSW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -82.01%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for Alpha Tau Medical Ltd - Warrants (07/03/2027), and consider following DRTSW for alerts when major investors trade the stock.